-
- 抗原 See all MEFV 抗体
- MEFV (Mediterranean Fever (MEFV))
-
抗原表位
- AA 5-39, N-Term
-
适用
- 人, 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This MEFV antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 原理
- Rabbit IgG polyclonal antibody for Pyrin(MEFV) detection. Tested with WB in Human,Rat.
- 序列
- PSDHLLSTLE ELVPYDFEKF KFKLQNTSVQ KEHSR
- 交叉反应 （详细）
- No cross reactivity with other proteins.
- 产品特性
-
Rabbit IgG polyclonal antibody for Pyrin(MEFV) detection. Tested with WB in Human,Rat.
Gene Name: Mediterranean fever
Protein Name: Pyrin - 纯化方法
- Immunogen affinity purified.
- 免疫原
- A synthetic peptide corresponding to a sequence at the N-terminus of human MEFV(5-39aa PSDHLLSTLEELVPYDFEKFKFKLQNTSVQKEHSR), different from the related mouse sequence by eight amino acids, and from the related rat sequence by eleven amino acids.
- 亚型
- IgG
- Top Product
- Discover our top product MEFV Primary Antibody
-
anti-Mediterranean Fever (MEFV) (AA 1-110) antibody
MEFV 适用: 人 WB, ELISA, IF 宿主: 小鼠 Monoclonal 2C1 unconjugated
anti-Mediterranean Fever (MEFV) (AA 1-110) antibodyMEFV 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Mediterranean Fever (MEFV) (Internal Region) antibodyVerified MEFV 适用: 人 ELISA, IF, FACS 宿主: 山羊 Polyclonal unconjugated
anti-Mediterranean Fever (MEFV) (AA 268-374) antibodyMEFV 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Mediterranean Fever (MEFV) (N-Term) antibodyMEFV 适用: 人, 小鼠, 犬, Cow, 豚鼠, Bat, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Mediterranean Fever (MEFV) (AA 418-445) antibodyMEFV 适用: 人 WB 宿主: 兔 Polyclonal RB41739 unconjugated
anti-Mediterranean Fever (MEFV) (N-Term) antibodyMEFV 适用: 人, 马, 兔, Pig WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Human, Rat
Notes: Tested Species: Species with positive results.
Other applications have not been tested. Optimal dilutions should be determined by end users. - 说明
-
Antibody can be supported by chemiluminescence kit ABIN921124 in WB.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
- 浓度
- 500 μg/mL
- 缓冲液
- Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Avoid repeated freezing and thawing.
- 储存条件
- 4 °C/-20 °C
- 储存方法
-
At -20°C for one year. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.
-
- 抗原
- MEFV (Mediterranean Fever (MEFV))
- 别名
- MEFV (MEFV 产品)
- 别名
- pyrin antibody, MEFV antibody, FMF antibody, MEF antibody, TRIM20 antibody, rfp domain antibody, MEFV, pyrin innate immunity regulator antibody, Mediterranean fever antibody, MEFV antibody, Mefv antibody
- 背景
-
MEFV (Mediterranean fever) is a human gene that provides instructions for making a protein called pyrin (also known as marenostrin). Pyrin is produced in certain white blood cells (neutrophils, eosinophils and monocytes) that play a role in inflammation and in fighting infection. Inside these white blood cells, pyrin is found with thecytoskeleton, the structural framework that helps to define the shape, size, and movement of a cell. Pyrin's protein structure also allows it to interact with other molecules involved in fighting infection and in the inflammatory response. Although pyrin's function is not fully understood, it likely assists in keeping the inflammation process under control. Research indicates that pyrin helps regulate inflammation by interacting with the cytoskeleton. And Pyrin may direct the migration of white blood cells to sites of inflammation and stop or slow the inflammatory response when it is no longer needed.
Synonyms: FMF antibody|Marenostrin antibody|Mediterranean fever antibody|Mediterranean fever protein antibody|MEF antibody|Mefv antibody| MEFV_HUMAN antibody|Pyrin antibody|TRIM20 antibody - 基因ID
- 4210
- UniProt
- O15553
- 途径
- Positive Regulation of Endopeptidase Activity
-
You are here:
